The Cord Blood Registry (CBR) is owned by CooperSurgical, a specialized operating company and subsidiary of the publicly traded global medical device corporation The Cooper Companies (NYSE: COO). CooperSurgical acquired CBR through its parent acquisition of Generate Life Sciences, integrating the world's largest family newborn stem cell and cord blood banking enterprise into its global healthcare portfolio.